Trials / Completed
CompletedNCT01418261
SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 535 (actual)
- Sponsor
- Medtronic Vascular · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The Symplicity HTN-3 study is a, multi-center, prospective, single-blind, randomized, controlled study of the safety and effectiveness of renal denervation in subjects with uncontrolled hypertension. Bilateral renal denervation will be performed using the Symplicity Catheter - a percutaneous system that delivers radiofrequency (RF)energy through the luminal surface of the renal artery.
Detailed description
The Symplicity HTN-3 study is a, multi-center, prospective, single-blind, randomized, controlled study of the safety and effectiveness of renal denervation in subjects with uncontrolled hypertension. Bilateral renal denervation will be performed using the Symplicity Catheter - a percutaneous system that delivers radiofrequency (RF)energy through the luminal surface of the renal artery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Renal denervation (Symplicity Catheter System) | |
| DIAGNOSTIC_TEST | Renal angiogram |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2013-12-01
- Completion
- 2017-02-17
- First posted
- 2011-08-17
- Last updated
- 2017-04-26
Locations
79 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01418261. Inclusion in this directory is not an endorsement.